Avanish Vellanki - Mar 11, 2022 Form 4 Insider Report for Rain Therapeutics Inc. (RAIN)

Role: President and CEO, Director
Signature: /s/ Nelson Cabatuan, Attorney-in-fact for Avanish Vellanki
Stock symbol: RAIN
Transactions as of: Mar 11, 2022
Transactions value $: $57,872
Form type: 4
Date filed: 3/15/2022, 03:23 PM
Previous filing: Feb 4, 2022
Next filing: Apr 15, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RAIN	Common Stock	Options Exercise	$57.9K	+14.5K	+0.51%	$4.00	2.84M	Mar 11, 2022	Direct
holding	RAIN	Common Stock						139K	Mar 11, 2022	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RAIN	Stock Option (Right to Buy)	Options Exercise	$0	-14.5K	-31.25%	$0.00	31.8K	Mar 11, 2022	Common Stock	14.5K	$4.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option represents a right to purchase a total of 46,300 shares of the Issuer's common stock, which vests in equal monthly installments through November 13, 2024, subject to the Reporting Person's continued service to the Issuer.